$BMRN

$66.02▲ +0.5% YTD

4 SEC 13D/G filings tracked · Last updated Sep 14, 2026

Filing History

BMRN ▲ +0.5% - BioMarin Pharmaceutical Inc.

CP $66.02▲ +0.5%Sep 14, 2026 · ThinkSabio Blog

$BMRN BMRN - BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors…

News

BMRN ▲ +0.2% - BioMarin Pharmaceutical Inc.

CP $64.80▲ +0.2%Sep 9, 2026 · ThinkSabio Blog

$BMRN BMRN - BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM Evidence…

News

BMRN ▲ +0.0% - BioMarin Pharmaceutical Inc.

CP $65.23▲ +0.0%Sep 1, 2026 · ThinkSabio Blog

$BMRN BMRN - BioMarin Announces Close of the Alesta Therapeutics Acquisition…

News

BMRN ▼ -0.9% - BioMarin Pharmaceutical Inc.

CP $64.67▲ -0.9%Aug 31, 2026 · ThinkSabio Blog

$BMRN BMRN - BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Braz…